Target intelligence / Profile preview

ATP-sensitive potassium channel regulatory subunit 1 (SUR1)

Target
SUR1
Molecular classification
ATP-binding cassette transporter, Ion channel regulatory subunit, ABC transporter family
01

Overview

The ATP-sensitive potassium channel regulatory subunit 1 (SUR1) is a key component of the K-ATP channel complex, primarily located in the plasma membrane of pancreatic beta cells (UniProt, 2024; NCBI Gene, 2024). Encoded by the ABCC8 gene, SUR1 belongs to the ATP-binding cassette (ABC) transporter superfamily but functions as a regulatory subunit rather than a transporter (UniProt, 2024). It assembles with the pore-forming Kir6.2 subunit to form an octameric complex that serves as a metabolic sensor, responding to changes in the intracellular ATP/ADP ratio (UniProt, 2024). When glucose levels rise, increased ATP production leads to channel closure, membrane depolarization, and the release of insulin (StatPearls, 2023). Mutations in SUR1 are associated with various glycemic disorders, including neonatal diabetes and hyperinsulinemic hypoglycemia (NCBI Gene, 2024). Beyond the pancreas, SUR1 is also upregulated in the central nervous system following injury, where it contributes to cerebral edema, making it a target for neuroprotective strategies (PubMed, 2017).

Other names
Sulfonylurea receptor 1ABCC8ABC36HHF1HIHRINSMRP8PHHIATP-binding cassette sub-family C member 8
02

Mechanism of action

Sulfonylureas and glinides act as agonists that bind to the SUR1 subunit to induce closure of the K-ATP channel, leading to beta-cell depolarization and insulin release (StatPearls, 2023). Conversely, potassium channel openers like diazoxide bind to SUR1 to maintain the channel in an open state, inhibiting insulin secretion (UniProt, 2024).

03

Biological functions

Insulin secretion regulationPotassium transportGlucose homeostasisMetabolic sensingMembrane potential regulation
04

Disease associations

Type 2 diabetes mellitusCongenital hyperinsulinismNeonatal diabetes mellitusIschemic strokeCerebral edemaTraumatic brain injury
05

Safety considerations

HypoglycemiaWeight gainSecondary failure of beta-cell functionOff-target cardiovascular effects via SUR2Sulfonamide allergy cross-reactivity
06

Interacting drugs

Glibenclamide

7 more in the full profile.

07

Biomarkers

Blood glucose levelsC-peptide levelsSerum insulinABCC8 gene mutations

Beyond the preview

Go deeper on ATP-sensitive potassium channel regulatory subunit 1 (SUR1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP-sensitive potassium channel regulatory subunit 1 (SUR1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call